Oxford Immunotec Global PLC Ordinary Shares
OXFD
OXFD was delisted on the 5th of March, 2021.
47 hedge funds and large institutions have $205M invested in Oxford Immunotec Global PLC Ordinary Shares in 2014 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 18 increasing their positions, 10 reducing their positions, and 6 closing their positions.
83% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 6
80% more repeat investments, than reductions
Existing positions increased: 18 | Existing positions reduced: 10
13% more capital invested
Capital invested by funds: $181M → $205M (+$23.9M)
12% more funds holding
Funds holding: 42 → 47 (+5)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Invesco
Atlanta,
Georgia
|
+$18M |
| 2 |
NCGI
Next Century Growth Investors
Plymouth,
Minnesota
|
+$6.51M |
| 3 |
O
OppenheimerFunds
New York
|
+$5.72M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$4.98M |
| 5 |
CAM
Cortina Asset Management
Milwaukee,
Wisconsin
|
+$4.7M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DCC
Dow Chemical Company
Midland,
Michigan
|
-$7.17M |
| 2 |
RG
Redmile Group
San Francisco,
California
|
-$6.96M |
| 3 |
PC
Polar Capital
London,
United Kingdom
|
-$5.83M |
| 4 |
FCM
Farallon Capital Management
San Francisco,
California
|
-$4.59M |
| 5 |
Alyeska Investment Group
Chicago,
Illinois
|
-$2.83M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
51
Bank of America
Charlotte,
North Carolina
| – | -$4.07K | -188 | -94% |
|
52
BlackRock
New York
| – | -$3K | -151 | Closed |
|
53
BNP Paribas Financial Markets
Paris,
France
| – | -$1.47K | -76 | Closed |
|
OXFD Hedge Fund Activity: Q1 2014 in Review
47 of the 3,462 institutional investors tracked by Wall St. Rank reported a position in Oxford Immunotec Global PLC Ordinary Shares (OXFD) for Q1 2014, worth a combined $205M — up 13% from $181M a quarter earlier.
Buyers outnumbered sellers: 11 funds opened new OXFD positions and 6 closed out — a net gain of 5 holders — while 18 added to existing stakes and 10 trimmed.
The largest buyer was Invesco, adding an estimated $18M. The largest seller was Dow Chemical Company, exiting entirely with an estimated $7.17M sold.
- 47 institutional investors held Oxford Immunotec Global PLC Ordinary Shares (OXFD) as of Q1 2014, up from 42 in Q4 2013.
- Funds reported $205M of Oxford Immunotec Global PLC Ordinary Shares stock for Q1 2014, up 13% quarter-over-quarter.
- 11 funds opened new Oxford Immunotec Global PLC Ordinary Shares positions in Q1 2014 and 6 closed out, a net change of +5 holders.
- The largest Oxford Immunotec Global PLC Ordinary Shares buyer in Q1 2014 was Invesco, an estimated $18M added.
- The largest Oxford Immunotec Global PLC Ordinary Shares seller in Q1 2014 was Dow Chemical Company, an estimated $7.17M sold.
Based on aggregated 13F filings for Q1 2014.